Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Thermo Scientific™ ImmunoCAP™ Egg and Fowl Allergens

Measure specifc IgE antibodies using ImmunoCAP™ allergens, an essential tool to aid in the diagnosis of allergic conditions.

$59.00 - $84.00

Specifications

Regulatory Status FDA Cleared
Code Type Egg and Fowl
View More Specs

Products 5
Catalog Number Mfr. No. Common Name Code Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Common Name Code Quantity Price Quantity & Availability  
14-411-101P
View Documents
Thermo Scientific™
14411101
Egg white f1 16 Tests
Pack of 16 for $84.00
Add to Cart
 
14-418-501P
View Documents
Thermo Scientific™
14418501
Chicken f83 16 Tests
Pack of 16 for $84.00
Add to Cart
 
14-418-401P
View Documents
Thermo Scientific™
14418401
Egg yolk f75 16 Tests
Pack of 16 for $84.00
Add to Cart
 
14-481-801P
View Documents
Thermo Scientific™
14481801
Turkey meat f284 10 Tests
Pack of 10 for $59.00
Add to Cart
 
14-482-601P
View Documents
Thermo Scientific™
14482601
Egg f245 10 Tests
Pack of 10 for $59.00
Add to Cart
 
Description

Description

Quantify specific IgE antibodies with the ImmunoCAP™ Egg and Fowl Allergens, essential tools to aid in the diagnosis of allergic conditions. IgE antibodies appear in human serum and plasma as a result of sensitization to a specific allergen. Measurement of circulating IgE antibodies provides an objective assessment of sensitization to an allergen. In general, low IgE antibody levels indicate a low probability of allergic disease, whereas high antibody levels to an allergen show a higher correlation with an allergic disease.

ImmunoCAP Specific IgE offers the laboratory:
  • Truly quantitative measuring range from 0.1 to 100 kUA/L
  • Intra-assay CV (%) comparable to routine clinical chemistry immunoassays
  • Excellent consistency over time, and between countries, systems, labs and persons
Expected test values
ImmunoCAP Specific IgE detects IgE antibodies in the range 0.1 to 100 kUA /l, where A represents allergen-specific antibodies. The result is reported quantitatively. In clinical practice, 0.35 kUA /l has commonly been used as a cut-off. A large number of studies have been performed to evaluate the clinical performance of ImmunoCAP Specific IgE tests in allergy diagnosis. Clinical performance is expressed as sensitivity, ranging from 84 to 95%, and specificity, ranging from 85 to 94%. Sensitivity and specificity were reported from multi-center studies including several hundred patients tested for a range of different allergens.
  • Specimen collection and preparation
  • Use serum and plasma (EDTA or heparin) samples from venous or capillary blood
  • Collect blood samples using standard procedures
  • Keep specimens at room temperature (RT) for shipping purposes only
  • Store at 2–8°C up to one week, otherwise store at –20°C
  • Avoid repeated freezing and thawing

Note: Blood samples for testing ImmunoCAP drugs and venom should be collected during or close to the event, preferably not later than 6 months after exposure. If the test result is negative and an IgE-mediated reaction is still strongly suspected, it is advisable to draw a new sample and repeat the test at 5 to 6 weeks.

The presence of specific IgE antibodies is useful to identify the allergens that elicit symptoms and signs of allergy in patients with respiratory allergic diseases including asthma, food allergy, and anaphylactic sensitivity.

Knowing IgE antibody levels provides guidance to clinicians to:
  • Identify offending allergens
  • Tailor advice to individual patients
  • Indicate development of tolerance (food allergy, specific immunotherapy)
  • Inform optimized individual medical treatment plans
  • Refer to specialists appropriately
  • Evaluate whether or not specific immunotherapy is an option

Specific IgE testing also aids in the identification of patients at risk of:
  • The allergy march – a progression of skin symptoms to respiratory symptoms
  • Severe symptoms including asthma exacerbations – a progression of mild symptoms to severe symptoms
  • Progression of recurrent symptoms to persistent symptoms

As in all diagnostic testing, a definitive clinical diagnosis should be made by the clinician after evaluation of all clinical and laboratory findings.
Specifications

Specifications

FDA Cleared
Egg and Fowl
SDS
Documents

Documents

Product Certifications
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit